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 CLINICAL PRESENTATION
A 69-year-old man was hospitalized for non-oliguric 
renal dysfunction. His medical history revealed 15 years 
of hypertension and 5 years of diabetes mellitus type 
2. He was regularly treated and controlled with met-
formin, sitagliptin, ramipril and hydroclorothyazide.
A diagnosis of gastro-oesophageal junction adeno-
carcinoma was done 20 months before admission. 
The patient was submitted to pre-operative EOX 
(Epirubicin, Oxaliplatin and Capecitabine) chemo-
therapy. A total gastrectomy was made with a Roux-
en-Y gastric bypass reconstruction. There was no 
cancer recurrence in the follow-up.
At post-surgical discharge time, 14 months before 
this hospitalization, the patient presented a normal 
renal function (creatinine of 0.8 mg/dl).
In the Emergency room, he presented creatinine 
of 10 mg/dl and normocytic normochromic anaemia 
with haemoglobin of 6.5 g/dl. Urine type II showed 
30 mg/dl of proteinuria, without erythrocytes or 
leucocytes.
The kidney ultrasound revealed a right kidney 
measuring 9.9 cm and a left kidney of 8.8cm, paren-
chymal hyperechogenicity with cortico-medullary 
dedifferentiation. Serology for HIV, HCV, HBV and 
immunological study was negative.
Haemodialysis was immediately initiated. Three days 
after admission a kidney biopsy was performed.
 HISTOLOGICAL FEATURES
The paraffin-embedded fragment presented a renal 
capsule, twelve glomeruli and some normal medium 
sized arteries. A frozen fragment with one glomerulus 
was used for immunofluorescence and was negative 
for the presence of IgG, IgA, IgM, C3, C1q, fibrinogen, 
albumin, kappa and lambda light chain.
The following figures presented the principal 
aspects of optical microscopy.
Figure 1 shows a predominantly interstitial nephrop-
athy. The glomerulus is apparently ischaemic. A tubule 
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Figure 1
Periodic acid Schiff; x200.
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presents intra-luminal abnormal substance. Figure 2 
evidences acute tubular necrosis; loss of proximal 
tubule brush border, luminal tubular expansion and 
epithelial tubule cells cytoplasm simplification can be 
seen. The glomerulus presents ischaemic aspects. The 
H&E coloration in Figure 3 demonstrates several intra- 
luminal translucent crystals. In Figure 4, an intra-
luminal translucent crystal is visible. The rest of the 
image shows irreversible tubular atrophy and inter-
stitial fibrosis. Figure 5 presents bright intra-tubular 
calcium oxalate crystals in H&E under polarized light.
 HISTOLOGICAL DIAGNOSIS
Oxalate nephropathy.
 DISCUSSION
The biopsy showed a predominant tubulo-inter-
stitial disease (Fig. 1) with some features more acute 
(Fig. 2) and others more chronic (Fig. 4). The 
Figure 2
Masson's trichrome green; x200.
Figure 4
Masson's trichrome green; x400.
Figure 3
Haematoxylin and eosin; x400.
Figure 5
Haematoxylin and eosin under polarized light;x40.
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ischaemic aspects of glomeruli seem essentially sec-
ondary to the interstitial lesions and fibrosis. The 
glomeruli did not present parietal alteration or 
immune deposition. Several translucent crystals were 
present in tubular lumens (Figs. 3 and 4) and were 
brilliant under polarized light (Fig. 5), which is char-
acteristic of calcium oxalate crystals. The calcium 
phosphate crystals do not change colour under polar-
ized light.
Several studies reported that patients undergoing 
Roux-en-Y gastric bypass (RYGB) are at risk for hyp-
eroxaluria, nephrolithiasis, and oxalate nephropa-
thy1-3. The RYGB procedures are currently the most 
common bariatric operation in the United States for 
medically complicated obesity1.
Nasr et al.4 reported the largest series (n = 11) 
of oxalate nephropathy after RYGB for the treatment 
of either morbid obesity or gastric adenocarcinoma. 
The median time from RYGB to diagnosis of acute 
renal failure was 12 months and patients frequently 
had a history of baseline renal insufficiency. Clinical 
prognosis was poor, with 73% of patients progress-
ing to end-stage renal disease within 3 months after 
diagnosis.
A study by Nordenvall et al.5 in the early 80s has 
indicated that these patients have a normal endog-
enous oxalate production but have hyperabsorption 
of dietary oxalate. The potential mechanism for hyp-
eroxaluria after RYGB is due to fat malabsorption 
and enhanced saponification of intestinal calcium6. 
Typical preventive strategies1,2 for hyperoxaluria are 
prescription of a low-fat, low-oxalate diet, generous 
fluid intake, and use of oral oxalate binders such as 
calcium. Foods high in oxalate are tea, nuts, spinach, 
rhubarb, and cocoa.
 TREATMENT AND EVOLUTION
No specific treatment was done. Recovery of renal 
function was not observed and this patient is in a 
regular haemodialysis programme.
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